The purpose of this study is to evaluate the diagnostic performance of 18F-FDG micro-PET-CT in malignant Head and neck cancer compared to definitive histological analysis (gold standard).
Signed informed consent
Adult, male or female, aged 18 or over
Patient with a malignant tumor of the oral cavity, oropharynx, hypopharynx, larynx, sinuses, or salivary glands, regardless of lymph node status (any N) M0, operable
Member or beneficiary of a social security plan
Child-Pugh C liver failure
Patients under guardianship, conservatorship, or legal protection
Patients deprived of their liberty
Pregnant or breastfeeding women
Single group
micro PET/CT
DevicePET/T of the speciment after surgery
Evaluate the diagnostic performance of 18F-FDG micro-PET-CT in malignant ENT tumors compared to definitive histological analysis (gold standard).
Estimate the performance of micro-FDG PET in defining surgical margins and compare with histology by measuring the number of quadrants affected by each technique on the surgical specimen
Click on the lead sponsor to view all of their trials.
